Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Sherman

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Eye & Contact Lens|June 23, 2025
Symptoms as an Indicator of Microbial Keratitis Severity and Its Association With Visual AcuityDena Ballouz, Leslie M Niziol, N Venkatesh Prajna, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 16, 2005
A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patientsRobert A Schnoll, Randi L Rothman, Dustin B Wielt, et al.
Head & Neck|June 24, 2014
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancersBenjamin H Lok, Christine Chin, Nadeem Riaz, et al.
Head & Neck|February 19, 2021
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapyKaveh Zakeri, Huili Wang, Jung Julie Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site DistributionsCharles C Berry, Christopher Nobles, Emmanuelle Six, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell CarcinomaSean McBride, Eric Sherman, C Jillian Tsai, et al.
JAMA Ophthalmology|August 22, 2024
A Screening Strategy to Mitigate Vision Impairment by Engaging Adults Who Underuse Eye Care ServicesEric Sherman, Leslie M Niziol, Patrice M Hicks, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Eye & Contact Lens|June 23, 2025
Symptoms as an Indicator of Microbial Keratitis Severity and Its Association With Visual AcuityDena Ballouz, Leslie M Niziol, N Venkatesh Prajna, et al.
Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine|August 16, 2005
A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patientsRobert A Schnoll, Randi L Rothman, Dustin B Wielt, et al.
Head & Neck|June 24, 2014
Irradiation for locoregionally recurrent, never-irradiated oral cavity cancersBenjamin H Lok, Christine Chin, Nadeem Riaz, et al.
Head & Neck|February 19, 2021
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapyKaveh Zakeri, Huili Wang, Jung Julie Kang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2026
Ficerafusp Alfa (BCA101) With Pembrolizumab for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Two-Year Results of an Expansion Cohort of a Phase I/Ib TrialGlenn J Hanna, Dan P Zandberg, Deborah J Wong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2008
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II studyEzra E W Cohen, Lee S Rosen, Everett E Vokes, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
A phase 1 study of everolimus + weekly cisplatin + intensity modulated radiation therapy in head-and-neck cancerMatthew G Fury, Nancy Y Lee, Eric Sherman, et al.
Molecular Therapy. Methods & Clinical Development|March 28, 2017
INSPIIRED: Quantification and Visualization Tools for Analyzing Integration Site DistributionsCharles C Berry, Christopher Nobles, Emmanuelle Six, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2020
Randomized Phase II Trial of Nivolumab With Stereotactic Body Radiotherapy Versus Nivolumab Alone in Metastatic Head and Neck Squamous Cell CarcinomaSean McBride, Eric Sherman, C Jillian Tsai, et al.
JAMA Ophthalmology|August 22, 2024
A Screening Strategy to Mitigate Vision Impairment by Engaging Adults Who Underuse Eye Care ServicesEric Sherman, Leslie M Niziol, Patrice M Hicks, et al.
Pageof 10